{ "items": [ "\n\n
\n \n\n \n \n \n \n FMRIB\n \n \n \n \n NDCN\n \n \n\n \n\n\n
\n \n \n \nWe use brain imaging techniques to investigate the human visual system, both in its normal state and in disease and disorder.
\n \n\n \n \n\n \n\n \n \n \n \n FMRIB\n \n \n\n \n\n\n
\n \n \n \nOur work focuses on translating imaging analysis methods to better understand processes such as brain maturation and ageing, and with a particular emphasis on neurodegenerative disorders (Alzheimer's, Parkinson's, Huntington's, ALS) and Big Data (UK Biobank, Lifespan HCP).
\n \n\n \n \n\n \n\n \n \n \n \n NDA\n \n \n \n \n NDCN\n \n \n\n \n\n\n
\n \n \n \nThe Critical Care Research Group undertakes a programme of research which focuses on the identification of early patient deterioration and long-term clinical outcomes of patients who have been admitted to an Intensive Care Unit.
\n \n\n \n \n\n \n\n \n \n \n \n DCN\n \n \n\n \n\n\n
\n \n \n \nWe want to understand how - and why - brain function can be disturbed to lead to poor memory and loss of motivation (apathy). Our aim is to develop new treatments for these conditions across a range of neurological disorders.
\n \n\n \n \n\n \n\n \n \n \n \n DCN\n \n \n\n \n\n\n
\n \n \n \nOur aim is to gain a better understanding of the response of the peripheral nervous system to injury in order to develop strategies to promote peripheral nerve repair and to prevent the development of neuropathic pain. To do this we employ a variety of multi-disciplinary techniques ranging from transgenic models to human psychophysical studies and genetics.
\n \n\n \n \n\n \n\n \n \n \n \n FMRIB\n \n \n\n \n\n\n
\n \n \n \nCombining state-of-the-art brain imaging methods, we aim to understand how functional networks in the brain respond and adapt to epilepsy and epilepsy-associated lesions.
\n \n\n \n \n\n \n\n \n \n \n \n FMRIB\n \n \n\n \n\n\n
\n \n \n \n\n \n \n\n \n\n \n \n \n \n NLO\n \n \n\n \n\n\n
\n \n \n \nThe Clinical Ophthalmology Research Group is led by Professor Robert MacLaren. Over the last decade, Professor MacLaren has been at the forefront of translational medical research into novel clinical treatments for incurable retinal diseases, and is regarded internationally as a leader in the fields of retinal gene therapy, electronic retinas and ocular robotic surgery.
\n \n\n \n \n\n \n\n \n \n \n \n NLO\n \n \n\n \n\n\n
\n \n \n \nOur research focuses on light dependent signalling in the retina and brain, including visual and non-visual light detection. We are also examining novel opsin photopigments and exploring their applications to optogenetics.
\n \n\n \n \n\n \n\n \n \n \n \n NLO\n \n \n\n \n\n\n
\n \n \n \nOur work involves the identification and characterisation of genes that play a role in the development, maintenance and function of the retina and includes both visual and non-image forming tasks.
\n \n\n \n \n\n \n\n \n \n \n \n NLO\n \n \n\n \n\n\n
\n \n \n \nOur research interests range across the neurosciences but with specific interests in circadian, visual and behavioural neuroscience.
\n \n\n \n \n\n \n\n \n \n \n \n NLO\n \n \n\n \n\n\n
\n \n \n \nOur research focuses on the non-image forming function of the eye, including how the light environment regulates sleep and circadian rhythms and how these responses are affected in disease.
\n \n\n \n \n\n \n\n \n \n \n \n NLO\n \n \n\n \n\n\n
\n \n \n \nThe discovery of a novel inner retinal photoreceptor cell, driving non-visual functions, has had a significant impact on the retinal neuroscience field. My research focuses on understanding the physiology and function of these photosensitive retinal ganglion cells.
\n \n\n \n \n\n \n\n \n \n \n \n FMRIB\n \n \n\n \n\n\n
\n \n \n \n\n \n \n\n \n\n \n \n \n \n FMRIB\n \n \n\n \n\n\n
\n \n \n \nWe develop techniques and hardware on the Centre\u2019s 7 Tesla MRI scanner to offer neuroscientists exciting new possibilities to image the structure, function and biochemistry of the human brain.
\n \n\n \n \n\n \n\n \n \n \n \n NDA\n \n \n\n \n\n\n
\n \n \n \nThe Oxford Respiratory Group works collaboratively on a range of projects dedicated to Respiratory Control. Professor Pandit's group studies anaesthetic effects on oxygen sensing and also focusses on clinical research related to effects of anaesthetics on respiration and anaesthetic techniques on the lungs and airway.
\n \n\n \n \n\n \n\n \n \n \n \n DCN\n \n \n \n \n FMRIB\n \n \n \n \n NDCN\n \n \n\n \n\n\n
\n \n \n \n\n \n \n\n \n\n \n \n \n \n DCN\n \n \n\n \n\n\n
\n \n \n \nNeuromyelitis optica (NMO) is a rare disease causing inflammation in the spinal cord and optic nerves. The NMO service brings together expertise in diagnostics and clinical management to improve outcomes for this often isolated group of patients.
\n \n\n \n \n\n \n\n \n \n \n \n FMRIB\n \n \n \n \n NDCN\n \n \n\n \n\n\n
\n \n \n \nNeuroplastics is a collaborative network of three research groups at WIN with a shared interest in brain plasticity. We study how the brain changes when we learn, as we get older, or when we recover from damage such as stroke. We use brain imaging to monitor brain change and we aim to develop new approaches to facilitate learning, recovery and healthy ageing.
\n \n\n \n \n\n \n\n \n \n \n \n FMRIB\n \n \n \n \n NDCN\n \n \n\n \n\n\n
\n \n \n \nWe study how the brain changes when we learn, as we get older, or when we recover damage such as stroke. We use brain imaging to monitor brain change and we aim to develop new approaches to facilitate learning, recovery and healthy brain development and ageing.
\n \n\n \n \n